Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 72 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8946243

    Compounds and methods for the treatment of viral infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  2. US 8946455

    Semi-synthetic small molecules for the treatment parasitic disease

    The Regents of the University of California · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  3. US 8946300

    Use of rasagilline for the treatment of restless legs syndrome

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  4. US 8940301

    Breast tumor treatment with anti-CXCR1 compositions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted

  5. AU 2013283318

    Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

    4SC DISCOVERY GMBH [DE] · Granted Jan 22, 2015 · Expires Jan 17, 2035

    granted

  6. US 8937178

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  7. US 8937099

    N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress

    SENTIENT LIFESCIENCES, INC. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  8. US 8937060

    1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  9. US 8936941

    Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  10. US 8932060

    Dental treatment method

    KURARAY NORITAKE DENTAL INC. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  11. US 8932588

    Treatment of cancer involving mutated KRAS or BRAF genes

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  12. US 8933030

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  13. US 8933216

    Immunosuppression compound and treatment method

    Sarepta Therapeutics, Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  14. US 8927495

    Use of GnRH and analogs thereof for the prevention and treatment of pet ferret adrenocortical hyperplasia

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  15. US 8927030

    Use of nitrite salts for the treatment of cardiovascular conditions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  16. US 8920800

    Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

    Five Prime Therapeutics, Inc. · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  17. US 8921340

    Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  18. US 8916603

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  19. US 8912214

    Use of Chk2 kinase inhibitors for cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  20. US 8912175

    Topical compositions for treatment of skin conditions

    Molecular Design International, Inc. · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  21. US 8911733

    Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  22. US 8906870

    MicroRNA (miRNA) for the diagnosis and treatment of heart diseases

    Julius-Maximilians-Universitat Wurzburg · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  23. US 8906853

    [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection

    Enanta Pharmaceuticals, Inc. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  24. US 8901309

    Fused triazoles for the treatment or prophylaxis of mild cognitive impairment

    Takeda Pharmaceutical Company Limited · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.